Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder: A 6-Month, Double-Blind Trial

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Psychopharmacology

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JCP.0b013e318192e4a0PMID 19142107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Reliability and Validity of Self- and Investigator Ratings of ADHD in Adults

  2008cited by this paper
• Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

  2008cited by this paper
• Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD

  2008cited by this paper
• Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment

  2007cited by this paper
• Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL)

  2007cited by this paper
• ADHD in Adults — A Familiar Disease with Unfamiliar Challenges

  2007cited by this paper
• The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

  2006cited by this paper
• Mixed Amphetamine Salts Extended-Release in the Treatment of Adult ADHD: A Randomized, Controlled Trial

  2006cited by this paper
• Validation of the Adult Attention-Deficit/Hyperactivity Disorder Quality-of-Life Scale (AAQoL): A Disease-Specific Quality-of-Life Measure

  2006cited by this paper
• A Randomized, Placebo-Controlled Trial of OROS Methylphenidate in Adults with Attention-Deficit/Hyperactivity Disorder

  2006cited by this paper
• Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD.

  2006cited by this paper
• Conceptualization and Assessment of Quality of Life for Adults with Attention- Deficit/Hyperactivity Disorder

  2005cited by this paper
• A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder.

  2005cited by this paper
• Pharmacotherapy of adult ADHD.

  2005cited by this paper
• Training Raters to Assess Adult ADHD: Reliability of Ratings

  2005cited by this paper
• The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population

  2005cited by this paper
• A clinical perspective of attention-deficit/hyperactivity disorder into adulthood.

  2004cited by this paper
• Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

  2004cited by this paper
• Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

  2004influential reference
• Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

  2003influential reference
• Management of ADHD in adults.

  2002cited by this paper
• Adults with ADHD

  2001cited by this paper

• Nasal Adverse Events Associated With Attention-Deficit Hyperactivity Disorder (ADHD) Medications: A Systematic Review, Meta-Analysis, and Implications for the Otolaryngologist

  2025influential citation
• Cannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects

  2025cites this paper
• Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder

  2024cites this paper
• A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy

  2024cites this paper
• Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment

  2024cites this paper
• Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder

  2024cites this paper
• Oral blood pressure augmenting agents for intravenous vasopressor weaning

  2024cites this paper
• Assessment of centanafadine in adults with attention-deficit/hyperactivity disorder: A matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release.

  2024cites this paper
• Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice Experiment

  2024cites this paper
• Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients

  2023influential citation
• Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis

  2023cites this paper
• Pilot Study of Prism EFP NeuroFeedback in Adult ADHD

  2023cites this paper
• Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

  2022cites this paper
• Attention-Deficit/Hyperactivity Disorder Clinical Practice Guideline

  2020cites this paper
• Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment

  2020cites this paper
• Sexual Function, Sexual Dysfunctions, and ADHD: A Systematic Literature Review.

  2020cites this paper
• Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients

  2020cites this paper
• Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis

  2020influential citation
• What Is a Clinically Relevant Improvement in Quality of Life in Adults With ADHD?

  2019cites this paper
• Pilot Study of Droxidopa With Carbidopa in Adults With ADHD

  2019cites this paper
• Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses

  2019cites this paper
• [Can ADHD have an adulthood onset?]

  2019cites this paper
• Pharmacotherapy of Obstructive Sleep Apnea: Is Salvation Just Around a Corner?

  2019cites this paper
• Mapping and comparing attitudes, practices and beliefs of physicians who treat ADHD in Serbia, Norway and Iceland

  2018cites this paper
• ADHD and Crime: What is the Relationship? Can Implementation of Pharmacological and Psychosocial Interventions facilitate Offender Rehabilitation?

  2018cites this paper
• Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder

  2017influential citation
• Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD

  2017cites this paper
• A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities

  2017cites this paper
• Do Pharmaceuticals Improve Driving in Individuals with ADHD? A Review of the Literature and Evidence for Clinical Practice

  2017cites this paper
• of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit / hyperactivity disorder

  2017influential citation
• The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (IV) - Non-Pharmacologic Treatment -

  2017cites this paper
• Pharmakotherapie der ADHS im Erwachsenenalter

  2017cites this paper
• The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder ( IV )-Non-Pharmacologic Treatment

  2017cites this paper
• Eficàcia, seguretat i abandonament del tractament farmacològic del trastorn per dèficit d’atenció amb hiperactivitat en pacients adults

  2017cites this paper
• An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD

  2017cites this paper
• Adult ADHD and substances

  2017cites this paper
• Positive effects of transcranial direct current stimulation in adult patients with attention-deficit/hyperactivity disorder - A pilot randomized controlled study.

  2017cites this paper
• Molecular Imaging in Adult Attention Deficit / Hyperactivity Disorder

  2016cites this paper
• Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database

  2016cites this paper
• Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.

  2016influential citation
• Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database

  2016cites this paper
• Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials

  2016influential citation
• A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients

  2016cites this paper
• The efficacy of atomoxetine in treating adult attention deficit hyperactivity disorder (ADHD): A meta-analysis of controlled trials.

  2016cites this paper
• Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities

  2016cites this paper
• Långtidsbehandling av ADHD : En litteraturstudie kring effekter av metylfenidat och atomoxetin vid minst sex månaders behandling

  2016cites this paper
• CYP2D6 predicted metabolizer status and safety in adult patients with attention‐deficit hyperactivity disorder participating in a large placebo‐controlled atomoxetine maintenance of response clinical trial

  2015cites this paper
• Understanding the treatment of attention deficit hyperactivity disorder in newly diagnosed adult patients in general practice: a UK database study

  2015cites this paper
• Patterns of long-term and short-term responses in adult patients with attention-deficit/hyperactivity disorder in a completer cohort of 12 weeks or more with atomoxetine

  2015cites this paper
• Long-Term, Open-Label, Safety Study of Edivoxetine as Adjunctive Treatment for Adult Patients with Major Depressive Disorder Who Were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment in Japan

  2015cites this paper
• A critical appraisal of atomoxetine in the management of ADHD

  2015cites this paper
• Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: An integrated analysis of 15 clinical trials

  2015cites this paper
• Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder

  2015cites this paper
• Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder

  2015cites this paper
• Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder

  2015influential citation
• Toward Quality Care in ADHD

  2015cites this paper
• Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients

  2015cites this paper
• Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysis

  2015cites this paper
• Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD

  2015cites this paper
• The Quality of Life (QoL) in Attention Deficit Hyperactivity Disorder (ADHD)

  2015cites this paper
• Atomoxetine for the Treatment of Adults with Attention Deficit Hyperactivity Disorder: A Cost-Utility Analysis in Spain

  2015cites this paper
• Neurochemical and neurophysiological bases of executive control

  2015cites this paper
• Attention-Deficit Hyperactivity Disorder in Adults and Children: ADHD diagnostic and symptom assessment scales for adults

  2015cites this paper
• Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung im Erwachsenenalter

  2015cites this paper
• Systematic Review of Patients’ and Parents’ Preferences for ADHD Treatment Options and Processes of Care

  2015cites this paper
• Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials

  2014cites this paper
• Open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention‐deficit/hyperactivity disorder

  2014cites this paper
• The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.

  2014cites this paper
• Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.

  2014cites this paper
• Suboptimal dosing of Strattera (atomoxetine) for ADHD patients.

  2014cites this paper
• Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.

  2014cites this paper
• Non-stimulant interventions in ADHD

  2014cites this paper
• Clinical Practice Guideline for Patients with Attention Deficit/Hyperactivity Disorder

  2014cites this paper
• Long‐term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder

  2014cites this paper
• Attention Benefits after a Single Dose of Metadoxine Extended Release in Adults with Predominantly Inattentive ADHD

  2014cites this paper
• Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care

  2014cites this paper
• Suboptimal Dosing of Strattera (Atomoxetine) for ADHD Patients

  2014cites this paper
• Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

  2013cites this paper
• Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine

  2013cites this paper
• Validation of the AQT Color–Form Additive Model for Screening and Monitoring Pharmacological Treatment of ADHD

  2013cites this paper
• Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine

  2013cites this paper
• Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta‐analysis and meta‐regression

  2013cites this paper
• Safety and Tolerability of Atomoxetine Hydrochloride in a Long-Term, Placebo-Controlled Randomized Withdrawal Study in European and Non-European Adults with Attention-Deficit/ Hyperactivity Disorder

  2013cites this paper
• Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.

  2013influential citation
• Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: a placebo-controlled, randomised withdrawal study

  2013cites this paper
• Managing ADHD in Adults with Common Comorbidities

  2013cites this paper
• Non-stimulant Drug Treatments for Adults with ADHD

  2013cites this paper
• A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.

  2013cites this paper
• Assessment of ADHD

  2013cites this paper
• Long-Term Treatment with Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder: An Open-Label Extension Study

  2013influential citation
• Profile of Sexual and Genitourinary Treatment-Emergent Adverse Events Associated with Atomoxetine Treatment: A Pooled Analysis

  2013cites this paper
• Developments and challenges in the diagnosis and treatment of ADHD.

  2013cites this paper
• Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis.

  2012cites this paper
• [Stimulant and non-stimulant medication in current and future therapy for ADHD].

  2012cites this paper
• Assessing attention-deficit/hyperactivity disorder in adults: A review of rating scales

  2012cites this paper
• Social skills and self-esteem of college students with ADHD

  2012cites this paper
• Pharmacotherapy for Parents with Attention-Deficit Hyperactivity Disorder (ADHD)

  2012cites this paper
• A quick test of cognitive speed for comparing processing speed to differentiate adult psychiatric referrals with and without attention-deficit/hyperactivity disorders.

  2012cites this paper
• Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

  2012cites this paper
• Off-label use of atomoxetine in adults: is it safe?

  2012cites this paper